Previous Close | 46.99 |
Open | 47.09 |
Bid | 0.00 x 900 |
Ask | 0.00 x 800 |
Day's Range | 47.00 - 47.21 |
52 Week Range | 39.65 - 52.81 |
Volume | |
Avg. Volume | 2,302,417 |
Market Cap | 14.009B |
Beta (5Y Monthly) | 0.17 |
PE Ratio (TTM) | 24.90 |
EPS (TTM) | 1.89 |
Earnings Date | Dec 04, 2024 - Dec 09, 2024 |
Forward Dividend & Yield | 1.48 (3.14%) |
Ex-Dividend Date | Oct 03, 2024 |
1y Target Est | 51.43 |
The drugs can also cause potential side effects, including a loss of muscle mass and digestive problems such as nausea, diarrhea and constipation. Survey data from consumer research firm Numerator reveals some unsurprising losers among food categories: Of 1,090 people using GLP-1s for weight loss (as opposed to diabetes), a net 38% say they are eating fewer cookies, pastries and cakes, making it the most affected category. In the Numerator survey, a net 42% of GLP-1 weight-loss users reported eating more fresh fruits and vegetables.
Brunch may never be the same again, thanks to the new V8 Grillo's Dill Pickle Bloody Mary Mix. Bloody Marys have long been the unofficial cocktail of weekend brunches, with nearly 3 in 4 Americans agreeing they enjoy sipping on this savory staple. Now brunch just got even better, with V8® and Grillo's Pickles coming together to create a fresh take on this classic cocktail, tapping into 2024's hottest flavor trend: pickles.